Effect of combined bevacizumab and temozolomide treatment on intramedullary spinal cord tumor.


STUDY DESIGN C6 glioma cells and an intramedullary spinal cord tumor model were used to evaluate the effect of bevacizumab (Avastin) or temozolomide (TMZ). OBJECTIVE In this study, we hypothesized that treatment with bevacizumab accelerates the therapeutic effect of TMZ on intramedullary gliomas in an animal model. SUMMARY OF BACKGROUND DATA Recently… (More)
DOI: 10.1097/BRS.0000000000000070


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.